Topics
Health
Pharma
Biotech
Politics & Policy
In the Lab
Business
Opinion
First Opinion
The Pharmalot View
Adam’s Take
Podcast
Video
Newsletters
Events
Upcoming Events
Webinars
STAT Expert Advantage
Log in
Subscribe
Newsletters
Try STAT Plus
Newsletters
Try STAT Plus
Gleevec
The Pharmalot View
Novartis, Colombia face off over cancer drug cost
By
Ed Silverman
Pharmalot
Colombia plans to unilaterally lower the cost of a Novartis cancer drug
By
Ed Silverman
advertisement
Pharmalot
House Democrats blast US Trade Rep for pressuring Colombia over Novartis patent
By
Ed Silverman
advertisement
Pharmalot
Colombian health minister is warned not to sidestep Novartis patent
By
Ed Silverman
Pharmalot
Colombian government recommendation puts Novartis cancer drug patent at jeopardy
By
Ed Silverman
Sign up for our Daily Recap newsletter
A roundup of STAT’s top stories of the day in science and medicine
Industry
Please select
Academia
Advertising/Marketing
Advocacy
Biotech
Consultancy/Firm
Financial Services
Government
Healthcare Payer
Healthcare Provider
Media
Medical Device
Non-profit
Pharma
Technology
Privacy Policy
Leave this field empty if you're human:
